Beta
0.93
-0.03-3.12%
03 January 2025
Summary:
Beta for Fennec Pharmaceuticals stock is 0.93, with the most recent change of -0.03 (-3.12%) on 03 January 2025. According to this value, FENC stock is less volatile than S&P 500 indexFENC Beta Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FENC Beta Performance
PeriodPeriod | BetaBeta | PricePrice | SPXSPX |
---|---|---|---|
todaytoday | -3.1% | -2.2% | +1.3% |
1 m1 month | +6.9% | -1.3% | -1.8% |
3 m3 months | +24.0% | +36.7% | +4.3% |
6 m6 months | +38.8% | -0.2% | +7.3% |
ytdytd | -3.1% | -2.7% | +1.0% |
1 y1 year | +29.2% | -43.1% | +26.3% |
5 y5 years | -30.6% | -6.3% | +83.7% |
FENC Beta High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | 0.99 | -6.1% | 0.86 | -7.5% |
3 m | 3 months | 0.99 | -6.1% | 0.68 | -26.9% |
6 m | 6 months | 0.99 | -6.1% | 0.60 | -35.5% |
1 y | 1 year | 0.99 | -6.1% | 0.60 | -35.5% |
3 y | 3 years | 0.99 | -6.1% | 0.27 | -71.0% |
5 y | 5 years | 1.38 | -32.6% | 0.27 | -71.0% |
alltime | all time | 2.76 | -66.3% | -50.36 | -5515.1% |
Fennec Pharmaceuticals Stock Beta History
Date | Value |
---|---|
2025 | 0.94(-2.1%) |
2024 | 0.96(+37.1%) |
2023 | 0.70(+59.1%) |
2022 | 0.44(-24.1%) |
Date | Value |
---|---|
2021 | 0.58(-39.6%) |
2020 | 0.96(-29.9%) |
2019 | 1.37(+270.3%) |
2018 | 0.37(-17.8%) |
2017 | 0.45 |
FAQ
- What is Fennec Pharmaceuticals beta?
- What is the all time high beta for Fennec Pharmaceuticals?
- What is FENC beta year-to-date change?
- What is Fennec Pharmaceuticals beta year-on-year change?
What is Fennec Pharmaceuticals beta?
The current beta of FENC is 0.93
What is the all time high beta for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high beta is 2.76
What is FENC beta year-to-date change?
Fennec Pharmaceuticals beta has changed by -0.03 (-3.12%) since the beginning of the year
What is Fennec Pharmaceuticals beta year-on-year change?
Over the past year, FENC beta has changed by +0.21 (+29.17%)